Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial.
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S. Ebata S, et al. Among authors: sato s. Lancet Rheumatol. 2021 Jul;3(7):e489-e497. doi: 10.1016/S2665-9913(21)00107-7. Epub 2021 May 26. Lancet Rheumatol. 2021. PMID: 38279402
Impact of guselkumab on three cases of SSc accompanying psoriasis.
Fukasawa T, Yoshizaki-Ogawa A, Yoshizaki A, Sato S. Fukasawa T, et al. Among authors: sato s. Rheumatology (Oxford). 2024 Jan 4;63(1):e6-e8. doi: 10.1093/rheumatology/kead287. Rheumatology (Oxford). 2024. PMID: 37310917 Free PMC article. No abstract available.
Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array.
Kuzumi A, Norimatsu Y, Matsuda KM, Ono C, Okumura T, Kogo E, Goshima N, Fukasawa T, Fushida N, Horii M, Yamashita T, Yoshizaki-Ogawa A, Yamaguchi K, Matsushita T, Sato S, Yoshizaki A. Kuzumi A, et al. Among authors: sato s. Front Immunol. 2023 Aug 28;14:1255540. doi: 10.3389/fimmu.2023.1255540. eCollection 2023. Front Immunol. 2023. PMID: 37701440 Free PMC article.
The Autoantibody Array Assay: A Novel Autoantibody Detection Method.
Norimatsu Y, Matsuda KM, Yamaguchi K, Ono C, Okumura T, Kogo E, Kotani H, Hisamoto T, Kuzumi A, Fukasawa T, Yoshizaki-Ogawa A, Goshima N, Sato S, Yoshizaki A. Norimatsu Y, et al. Among authors: sato s. Diagnostics (Basel). 2023 Sep 13;13(18):2929. doi: 10.3390/diagnostics13182929. Diagnostics (Basel). 2023. PMID: 37761295 Free PMC article.
Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome.
Matsuda KM, Kotani H, Yamaguchi K, Ono C, Okumura T, Ogawa K, Miya A, Sato A, Uchino R, Yumi M, Matsunaka H, Kono M, Norimatsu Y, Hisamoto T, Kawanabe R, Kuzumi A, Fukasawa T, Yoshizaki-Ogawa A, Okamura T, Shoda H, Fujio K, Matsushita T, Goshima N, Sato S, Yoshizaki A. Matsuda KM, et al. Among authors: sato a, sato s. Rheumatology (Oxford). 2024 Oct 1;63(10):2865-2873. doi: 10.1093/rheumatology/keae063. Rheumatology (Oxford). 2024. PMID: 38290780
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial.
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Okiyama N, Kodera M, Hasegawa M, Sato S. Ebata S, et al. Among authors: sato s. Lancet Rheumatol. 2022 Aug;4(8):e546-e555. doi: 10.1016/S2665-9913(22)00131-X. Epub 2022 Jun 28. Lancet Rheumatol. 2022. PMID: 38294008 Clinical Trial.
12,242 results
You have reached the last available page of results. Please see the User Guide for more information.